Compare VIR & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | REAL |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2019 | 2019 |
| Metric | VIR | REAL |
|---|---|---|
| Price | $10.59 | $10.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $21.00 | $18.00 |
| AVG Volume (30 Days) | 1.8M | ★ 2.8M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.49 | ★ 43.55 |
| EPS | N/A | ★ N/A |
| Revenue | $68,556,000.00 | ★ $692,845,000.00 |
| Revenue This Year | $257.66 | $14.82 |
| Revenue Next Year | N/A | $11.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.38 |
| 52 Week Low | $4.82 | $8.05 |
| 52 Week High | $12.00 | $17.39 |
| Indicator | VIR | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 61.88 |
| Support Level | $10.00 | $10.51 |
| Resistance Level | $11.83 | $11.98 |
| Average True Range (ATR) | 0.62 | 0.53 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 30.62 | 86.15 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.